Alopecia, a new US drug treats 40% of patients: the FDA asked for ok
A new alopecia drug shows impressive results. Here are the updates from phase three of the trial
Read moreA new alopecia drug shows impressive results. Here are the updates from phase three of the trial
Read moreThe idea of startups is to take ordinary cells from patients, such as skin cells, and turn them into hair-forming cells.
Read moreThe confirmation of the close relationship between stress and hair graying brings collateral and truly surprising results on the reversibility of aging.
Read moreBaldness, an ugly beast that can affect up to 85% of men after the age of 50. Until now. Today ...
Read moreA personalized shampoo based on your personal data, which is only good for you. Does it have a future? Who invests in ...
Read moreMany ways against hair loss, few definitive solutions. But this seems a good way: mRNA for regrowth ...
Read moreIntelligent reuse also extends to electronic devices: from hair cut the base for matrixes of OLED screens.
Read moreA research born to understand the phenomenon of gray hair has led to a new paradigm on stem cells. Could you give us ...
Read moreFor the first time scientific evidence arrives: pollution causes hair loss, breaking down the proteins responsible for their growth
Read moreIt works very well in the early stages of baldness (when alopecia is still patchy). No ringlets for anyone who is a ball ...
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.